RVPH
REVIVA PHARMA HLDGS INC
RVPH
RVPH
Delisted
RVPH was delisted on the 13th of May, 2026.
35 hedge funds and large institutions have $2.13M invested in REVIVA PHARMA HLDGS INC in 2026 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
33% less capital invested
Capital invested by funds: $3.18M → $2.13M (-$1.05M)
41% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 22
Holders
35
Holding in Top 10
–
Calls
$1.39M
Puts
$30K
Top Buyers
| 1 | +$3.47M | |
| 2 | +$3.1M | |
| 3 | +$2.69M | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$1.19M |
| 5 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$413K |
Top Sellers
| 1 | -$250K | |
| 2 | -$155K | |
| 3 | -$155K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$57.8K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$45.8K |
